Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (11-20 of 357) with videos related to

Pageof 36
Sort By:
Current Gastroenterology Reports|April 29, 2010
Antifibrotic therapies: will we ever get there?Alexander James Thompson, Keyur Patel
Current Opinion in Gastroenterology|March 28, 2014
Current status of fibrosis markersKeyur Patel, Nicholas A Shackel
Gastroenterology & Hepatology|February 18, 2017
Clinical Utility of Biomarkers of Liver FibrosisKeyur Patel, Don C Rockey
Lancet (London, England)|December 31, 2003
Selective decontamination of digestive tract in intensive careMartin E Stryjewski, Keyur Patel
Postgraduate Medicine|July 24, 2003
Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patientsKeyur Patel, John G McHutchison
Hepatology (Baltimore, Md.)|October 31, 2002
Future therapy of hepatitis CJohn G McHutchison, Keyur Patel
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice?Indra Neil Guha, Keyur Patel
Cleveland Clinic Journal of Medicine|October 8, 2004
Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and durationKeyur Patel, John G McHutchison
Intervirology|July 19, 2014
Therapy of acute and fulminant hepatitis BHans L Tillmann, Keyur Patel
3 Biotech|August 29, 2022
pCold-assisted expression of a thermostable xylanase from <i>Bacillus</i> <i>amyloliquefaciens</i>: cloning, expression and characterizationDharti Keyur Patel, Gayatri Dave
Pageof 36

Showing results (11-20 of 357) with videos related to

Sort By:
Pageof 36
Current Gastroenterology Reports|April 29, 2010
Antifibrotic therapies: will we ever get there?Alexander James Thompson, Keyur Patel
Current Opinion in Gastroenterology|March 28, 2014
Current status of fibrosis markersKeyur Patel, Nicholas A Shackel
Gastroenterology & Hepatology|February 18, 2017
Clinical Utility of Biomarkers of Liver FibrosisKeyur Patel, Don C Rockey
Lancet (London, England)|December 31, 2003
Selective decontamination of digestive tract in intensive careMartin E Stryjewski, Keyur Patel
Postgraduate Medicine|July 24, 2003
Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patientsKeyur Patel, John G McHutchison
Hepatology (Baltimore, Md.)|October 31, 2002
Future therapy of hepatitis CJohn G McHutchison, Keyur Patel
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice?Indra Neil Guha, Keyur Patel
Cleveland Clinic Journal of Medicine|October 8, 2004
Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and durationKeyur Patel, John G McHutchison
Intervirology|July 19, 2014
Therapy of acute and fulminant hepatitis BHans L Tillmann, Keyur Patel
3 Biotech|August 29, 2022
pCold-assisted expression of a thermostable xylanase from <i>Bacillus</i> <i>amyloliquefaciens</i>: cloning, expression and characterizationDharti Keyur Patel, Gayatri Dave
Pageof 36